Published in Breast on April 01, 2001
CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer. Biomed Res Int (2013) 0.87
Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls. BMC Cancer (2008) 0.86
Local adipocytes enable estrogen-dependent breast cancer growth: Role of leptin and aromatase. Adipocyte (2013) 0.85
The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer. PLoS One (2015) 0.75
S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer. Int J Clin Exp Pathol (2015) 0.75
Breast weight and hormone receptor status in women with breast cancer. Int Semin Surg Oncol (2005) 0.75
Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract (1995) 3.82
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol (2001) 3.49
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J Clin Oncol (1999) 1.98
Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. Am J Med (1990) 1.95
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging (2006) 1.91
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut (1994) 1.82
Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry (1985) 1.73
Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res (1985) 1.70
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Occurrence and clinical significance of overt blood loss per rectum in the general population and in medical practice. Br J Gen Pract (1994) 1.65
The incidence and outcome of rectal bleeding in general practice. Fam Pract (1993) 1.62
[Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology]. Ned Tijdschr Geneeskd (2000) 1.59
Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology (2007) 1.57
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology (2011) 1.56
Dietary habits, sexual maturation, and plasma hormones in pubertal girls: a longitudinal study. Am J Clin Nutr (1991) 1.49
Effect of obstetric team training on team performance and medical technical skills: a randomised controlled trial. BJOG (2012) 1.44
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J Clin Endocrinol Metab (1992) 1.44
Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res (1996) 1.42
Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int (2005) 1.42
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. J Nucl Med (1996) 1.42
Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer. Ann Oncol (1999) 1.42
[Palliative treatment of bone metastases with bone-seeking radionuclides]. Ned Tijdschr Geneeskd (1998) 1.39
Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet (2001) 1.38
Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient. Clin Chem (1996) 1.38
[Fever due to antithyroid agents]. Ned Tijdschr Geneeskd (1999) 1.38
[A patient with an extremely severe immunohaemolytic anemia due to diclofenac]. Ned Tijdschr Geneeskd (2004) 1.37
Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood (1996) 1.35
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia (1999) 1.34
Long-term quality of life of patients with head and neck cancer. Laryngoscope (2000) 1.32
Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol (2003) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry (1987) 1.30
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30
CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology (2009) 1.30
Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol (1988) 1.29
Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry. J Histochem Cytochem (1987) 1.27
Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest (1996) 1.25
Recovery of adrenocortical function during long-term treatment with corticosteroids. Br Med J (1970) 1.25
Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol (2001) 1.23
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology (2010) 1.22
Concentration of sex steroids in adipose tissue after menopause. Steroids (1998) 1.17
Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care (1996) 1.16
Extrapulmonary small-cell carcinoma: report of three cases and update of therapy and prognosis. Neth J Med (2000) 1.16
Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia (1992) 1.15
High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab (1986) 1.13
Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck (2000) 1.13
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. Br J Cancer (2000) 1.11
Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.11
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology (2009) 1.10
Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis (1987) 1.08
A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol (1999) 1.08
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07
Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat (1997) 1.07
Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg (1993) 1.07
Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol (2010) 1.06
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology (2008) 1.05
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate (1993) 1.05
Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J Clin Endocrinol Metab (1990) 1.04
Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract (1988) 1.04
Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) (1986) 1.04
Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res (1987) 1.03
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism (1993) 1.02
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood (1997) 1.01
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dement Geriatr Cogn Disord (2010) 1.01
A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study. Qual Saf Health Care (2010) 1.01
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck (1999) 1.00
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer (1999) 1.00
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol (1993) 0.99
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol (1985) 0.98
Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab (1976) 0.98
Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology (2000) 0.98
In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol (1991) 0.98
Heritability of reproductive hormones in adult male twins. Hum Reprod (2007) 0.97
The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer (1988) 0.97
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril (2000) 0.97
Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod (2009) 0.97
Adrenal androgens and aggression in conduct disorder prepubertal boys and normal controls. Biol Psychiatry (1998) 0.96
Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception (1990) 0.95
C-peptide. Diabetes Care (1983) 0.95
Prevention of exercise-induced muscle membrane damage by oestradiol. Life Sci (1988) 0.94
Hydrocortisone-production rates in Africans. Lancet (1967) 0.94
The behaviour of the plasma free testosterone/cortisol ratio during a season of elite rowing training. Int J Sports Med (1991) 0.93
Low incidence of p53 mutations in UVA (365-nm)-induced skin tumors in hairless mice. Cancer Res (1997) 0.93
Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol (1997) 0.93
Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls. J Am Acad Child Adolesc Psychiatry (2000) 0.92
The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacology (Berl) (1998) 0.92
Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. Cancer Res (1985) 0.92
Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons. Gynecol Endocrinol (1992) 0.92
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors. Cancer Lett (1997) 0.92
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome. Mult Scler (2012) 0.92